{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:38:10Z","timestamp":1791945490950,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.maturitas.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T23:02:43Z","timestamp":1660172563000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Dyslipidemia in midlife women: Approach and considerations during the menopausal transition"],"prefix":"10.1016","volume":"166","author":[{"given":"Nare","family":"Torosyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Visrodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Torbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo B.","family":"Minissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisandra L.","family":"Shufelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.maturitas.2022.08.001_bb0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12471-010-0841-y","article-title":"Gender differences in coronary heart disease","volume":"18","author":"Maas","year":"2010","journal-title":"Neth. Hear. J."},{"issue":"4","key":"10.1016\/j.maturitas.2022.08.001_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann. Intern. Med."},{"issue":"18","key":"10.1016\/j.maturitas.2022.08.001_bb0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women","volume":"316","author":"Colditz","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2022.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/GME.0000000000001424","article-title":"The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)","volume":"26","author":"El Khoudary","year":"2019","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.maturitas.2022.08.001_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0030","article-title":"Awareness and related factors of dyslipidemia in menopausal women in Korea","volume":"10","author":"Jeong","year":"2022","journal-title":"Healthcare (Basel)"},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jc.2006-1393","article-title":"Changes in body composition in women over six years at midlife: ovarian and chronological aging","volume":"92","author":"Sowers","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ije\/19.1.42","article-title":"Menopause-related changes in lipoproteins and some other cardiovascular risk factors","volume":"19","author":"Bonithon-Kopp","year":"1990","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0091-7435(82)90015-9","article-title":"Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in G\u00f6teborg, Sweden","volume":"11","author":"Lindquist","year":"1982","journal-title":"Prev Med"},{"issue":"25","key":"10.1016\/j.maturitas.2022.08.001_bb0055","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.13085","article-title":"Effects of gender, age and menopausal status on serum apolipoprotein concentrations","volume":"85","author":"Anagnostis","year":"2016","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2015.02.262","article-title":"Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions","volume":"81","author":"Anagnostis","year":"2015","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0021-9150(93)90225-J","article-title":"Influence of age and menopause on serum lipids and lipoproteins in healthy women","volume":"98","author":"Stevenson","year":"1993","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.maturitas.2022.08.001_bb0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2796.1999.00547.x","article-title":"Menopausal status and risk factors for cardiovascular disease","volume":"246","author":"Peters","year":"1999","journal-title":"J. Intern. Med."},{"issue":"20","key":"10.1016\/j.maturitas.2022.08.001_bb0085","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular diseaseFour prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.maturitas.2022.08.001_bb0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacl.2016.04.008","article-title":"Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression","volume":"10","author":"El Khoudary","year":"2016","journal-title":"J. Clin. Lipidol."},{"issue":"Suppl 1","key":"10.1016\/j.maturitas.2022.08.001_bb0100","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1136\/jech.56.suppl_1.i19","article-title":"Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe","volume":"56","author":"Bots","year":"2002","journal-title":"J. Epidemiol. Community Health"},{"issue":"9","key":"10.1016\/j.maturitas.2022.08.001_bb0105","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1210\/jc.2016-2144","article-title":"Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause","volume":"101","author":"El Khoudary","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2004.07.011","article-title":"Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women","volume":"177","author":"Zago","year":"2004","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.117.307025","article-title":"From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease","volume":"38","author":"Sacks","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.maturitas.2022.08.001_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073967","article-title":"The current status of research on high-density lipoproteins (HDL): a paradigm shift from HDL quantity to HDL quality and HDL functionality","volume":"23","author":"Cho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/2047487319848214","article-title":"HDL: fact, fiction, or function?HDL cholesterol and cardiovascular risk","volume":"28","author":"Allard-Ratick","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.maturitas.2022.08.001_bb0130","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","article-title":"Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from european cardiologists, gynaecologists, and endocrinologists","volume":"42","author":"Maas","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.maturitas.2022.08.001_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.10.005","article-title":"Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women","volume":"184","author":"Gregersen","year":"2019","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0140","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974\u20132000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2022.08.001_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.maturitas.2020.03.007","article-title":"Menopause symptom management in women with dyslipidemias: an EMAS clinical guide","volume":"135","author":"Anagnostis","year":"2020","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2022.08.001_bb0150","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.GME.0000064866.58809.E5","article-title":"Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study","volume":"10","author":"Hemelaar","year":"2003","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jwh.2011.2839","article-title":"Are all estrogens created equal? A review of oral vs. transdermal therapy","volume":"21","author":"Goodman","year":"2012","journal-title":"J. Women's Health (Larchmt)"},{"issue":"21","key":"10.1016\/j.maturitas.2022.08.001_bb0160","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ajhp\/57.21.1963","article-title":"Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women","volume":"57","author":"Contreras","year":"2000","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0165","first-page":"706","article-title":"Sex-specific determinants of coronary artery disease and atherosclerotic risk factors: estrogen and beyond","volume":"36","author":"Feldman","year":"2020","journal-title":"Can. J. Cardiol."},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2275(20)30144-9","article-title":"Estrogen receptor-mediated repression of human hepatic lipase gene transcription","volume":"43","author":"Jones","year":"2002","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12944-017-0612-5","article-title":"The effects of progesterones on blood lipids in hormone replacement therapy","volume":"16","author":"Jiang","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.maturitas.2022.08.001_bb0180","series-title":"Endotext, MDText.com, Inc. Copyright \u00a9 2000-2022","article-title":"The effect of endocrine disorders on lipids and lipoproteins","author":"Feingold","year":"2000"},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal womenprincipal results from the women's health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.maturitas.2022.08.001_bb0190","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2022.08.001_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2017.02.009","article-title":"The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis","volume":"99","author":"Anagnostis","year":"2017","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.maturitas.2022.08.001_bb0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet. Gynecol. Sci."},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0220","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.metabol.2016.01.006","article-title":"Metabolic profile in women with polycystic ovary syndrome across adult life","volume":"65","author":"Echibur\u00fa","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.maturitas.2022.08.001_bb0225","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J. Women's Health (Larchmt)"},{"issue":"12","key":"10.1016\/j.maturitas.2022.08.001_bb0230","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"24","key":"10.1016\/j.maturitas.2022.08.001_bb0235","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0240","article-title":"Lipid profile of women with premature ovarian failure","volume":"15","author":"Knauff","year":"2008","journal-title":"Menopause"},{"issue":"11","key":"10.1016\/j.maturitas.2022.08.001_bb0245","article-title":"Serum lipid levels in women with premature ovarian failure","volume":"19","author":"Gulhan","year":"2012","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.maturitas.2022.08.001_bb0250","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2004-0432","article-title":"Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk","volume":"89","author":"Carr","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2022.08.001_bb0255","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/jwh.2004.13.1119","article-title":"The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia","volume":"13","author":"Kolovou","year":"2004","journal-title":"J. Women's Health (Larchmt)"},{"issue":"25","key":"10.1016\/j.maturitas.2022.08.001_bb0260","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"Khoudary","year":"2020","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.maturitas.2022.08.001_bb0265","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.maturitas.2022.08.001_bb0270","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.maturitas.2022.08.001_bb0275","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jacl.2022.05.001","article-title":"Statin therapy for primary prevention in women: what is the role for coronary artery calcium?","volume":"16","author":"Grundy","year":"2022","journal-title":"J. Clin. Lipidol."},{"issue":"22","key":"10.1016\/j.maturitas.2022.08.001_bb0280","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1001\/jama.2017.18261","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US preventive services task force recommendation statement","volume":"318","author":"Grossman","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"European Heart Journal"},{"key":"10.1016\/j.maturitas.2022.08.001_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2020.12.013","article-title":"New cardiovascular prevention guidelines: how to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?","volume":"319","author":"Atar","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2022.08.001_bb0295","article-title":"New and emerging lipid-modifying drugs to lower LDL cholesterol","volume":"10","author":"Kosmas","year":"2021","journal-title":"drugsContext"},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40259-019-00399-6","article-title":"Small interfering RNA therapeutic inclisiran: a new approach to targeting PCSK9","volume":"34","author":"German","year":"2020","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.maturitas.2022.08.001_bb0305","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clinthera.2020.12.001","article-title":"Bempedoic acid: a new tool in the Battle against hyperlipidemia","volume":"43","author":"Powell","year":"2021","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.maturitas.2022.08.001_bb0310","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia","volume":"78","author":"Virani","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-020-0823-5","article-title":"Pemafibrate, a new selective PPAR\u03b1 modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases","volume":"22","author":"Yamashita","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"4","key":"10.1016\/j.maturitas.2022.08.001_bb0320","first-page":"521","article-title":"Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group","volume":"96","author":"Kurabayashi","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0325","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1210\/clinem\/dgab876","article-title":"New therapies for primary hyperlipidemia","volume":"107","author":"Aguilar-Salinas","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.maturitas.2022.08.001_bb0330","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jacc.2020.11.079","article-title":"New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B: JACC focus seminar 1\/4","volume":"77","author":"Nurmohamed","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.maturitas.2022.08.001_bb0335","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and tribulations of CETP inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.maturitas.2022.08.001_bb0340","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.maturitas.2022.08.001_bb0345","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/GME.0000000000000900","article-title":"Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data","volume":"24","author":"Archer","year":"2017","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.08.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1097\/GRF.0000000000000364","article-title":"Differential effects of progestogens used for menopausal hormone therapy","volume":"61","author":"Van Heertum","year":"2018","journal-title":"Clin. Obstet. Gynecol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222001724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222001724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:20:18Z","timestamp":1759915218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512222001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"alternative-id":["S0378512222001724"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.08.001","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidemia in midlife women: Approach and considerations during the menopausal transition","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}